LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 83 filers reported holding LION BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is 4.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $316,000 | +83.7% | 42,334 | +71.3% | 0.03% | +42.9% |
| Q4 2016 | $172,000 | -34.6% | 24,718 | -22.6% | 0.02% | -22.2% |
| Q3 2016 | $263,000 | +3187.5% | 31,945 | +3094.5% | 0.03% | +2600.0% |
| Q2 2016 | $8,000 | -90.5% | 1,000 | -93.9% | 0.00% | -91.7% |
| Q1 2016 | $84,000 | +147.1% | 16,500 | +345.9% | 0.01% | +140.0% |
| Q2 2015 | $34,000 | +126.7% | 3,700 | +208.3% | 0.01% | +150.0% |
| Q1 2015 | $15,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
| ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
| P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
| Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
| NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
| Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
| Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
| QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
| Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |